|
|||||
|
|
Patient outcomes and amotosalen/UVA‐treated platelet utilization in massively transfused patients |
|
| Authors: | W. Nussbaumer M. Amato H. Schennach M. Astl C. Y. Chen J.‐S. Lin L. Corash R. J. Benjamin |
| Affiliation: | 1. Central Institute for Blood Transfusion and Immunology, Medical University Hospital Innsbruck, Innsbruck, Austria;2. Cerus Corporation, Concord, CA, USA |
| Abstract: | |
| Keywords: | amotosalen INTERCEPT Blood System massive transfusion pathogen reduction platelets |